About Kevin Bitterman
Form D filings for Kinaset Therapeutics from 2020 to 2023 list Kevin Bitterman as director.
Kevin Bitterman first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Kevin Bitterman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kevin Bitterman works with at each company, as listed on that company's latest Form D.
Kinaset Therapeutics, Inc. · Form D/A, Jul 17, 2023
TK
Tom King
Director
JB
Jamil Beg
Director
RC
Robert Clarke
Chief Executive Officer and director
BV
Bram Vanparys
Director
FM
Frazer Morgan
Chief Development Officer
RH
Roger Heerman
Chief Business Officer and Chief Operating Officer